Subjects from a weight loss trial who achieved any remission from Type 2 diabetes also achieved a 40% lower rate of cardiovascular disease (CVD) and a 33% lower… read more.
Researchers from a large retrospective study report that, among patients diagnosed with COPD (chronic obstructive pulmonary disease), gabapentinoid use appears to be associated with an increase in the… read more.
For people with hearing loss, the risk of death is lower among those who regularly use a hearing aid, researchers reported on Jan. 3, 2024 in The Lancet… read more.
Researchers from a Taiwanese study report that an increase in the risk of miscarriage is associated with benzodiazepine use during pregnancy, after adjustments for cofounders. The findings appeared… read more.
Dulaglutide. a Type 2 diabetes treatment, appears to significantly lower the risk of weight gain among women who have stopped smoking, researchers reported after a secondary analysis of… read more.
Glucagon-like receptor agonists (GLP-1 RAs), a class of type 2 diabetes drug treatments, appear to also reduce the risk of colorectal cancer (CRC) researchers reported on Dec. 7,… read more.
A study of data from over 9.000 pregnancies in the U.S. indicates that cannabis exposure during pregnancy is associated with a composite of unhealthy pregnancy outcomes, especially low… read more.
Triptan, ergot and anti-emetic medications appear to be two to five times more effective than ibuprofen for treating migraine, researchers reported on Nov. 29, 2023 in Neurology. “There… read more.
Covid-19 vaccination prior to infection significantly reduces the risk of developing post-covid-condition (PCC), commonly known as long covid, researchers reported on Nov. 22, 2023 in The BMJ/British Medical… read more.
Patients treated with the investigative PCSK9 inhibitor recaticimab have achieved highly significant reducions in bad cholesterol, and they have done so with less frequent injections than patients treated… read more.
Researchers from a study of patients treated for acute COVID-19 report that virologic rebound takes place in about 20.8 percent of subjects treated with nirmatrelvir-ritonavir (N-R, Paxlovid) versus… read more.
Women who get a false-positive mammogram reading are more likely to develop breast cancer over the ensuing 20 years, researchers reported on Nov. 2, 2023 in JAMA Oncology. As… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
